ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase III Trial in Patients with Generalized Myasthenia Gravis
September 28, 2021Cutting-edge health technology company, LifeWave, has solidified its place as one of America's fastest growing privately held companies by again making the Inc. 5000 list for 2021. -
Harbour BioMed Reports Positive Topline Results from Phase 2 Trial of Batoclimab (HBM9161) in Generalized Myasthenia Gravis
July 07, 2021Harbour BioMed announced positive topline results from its Phase 2 proof-of-concept clinical trial of batoclimab (HBM9161) in Chinese generalized myasthenia gravis (gMG) patients.
Pharma Sources Insight January 2025
